Conclusions3dacquisitioncanreduce the acquisition timeinclinical study. Underordinarycondition, theimagingquality of 3d makes nodifferencewith2d, but it is better than 2d inlowerdose.
When you consider the percentage of these people who either already have a pre-existing condition or will likely develop one, the vote makes absolutely no sense whatsoever.